Laboratorios Richmond SACIF (RICH) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Laboratorios Richmond SACIF (RICH) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AR$202.02 Million ≈ $146.18K USD) by net assets (AR$72.73 Billion ≈ $52.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Laboratorios Richmond SACIF - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Laboratorios Richmond SACIF's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Laboratorios Richmond SACIF for a breakdown of total debt and financial obligations.

Laboratorios Richmond SACIF Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Laboratorios Richmond SACIF ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Advero Properties SOCIMI S.A. MC:YADV	0.008x
Sutro Biopharma NASDAQ:STRO	0.438x
Grimoldi SA BA:GRIM	-0.037x
Popular Vehicles and Services Limited NSE:PVSL	-0.018x
Tenax Therapeutics Inc NASDAQ:TENX	-0.095x
Trias Sentosa Tbk JK:TRST	0.029x
Fecon Foundation Engineering and Underground Construction JSC VN:FCN	0.109x
Wanshih Electronic Co Ltd TWO:6134	-0.054x

Annual Cash Flow Conversion Efficiency for Laboratorios Richmond SACIF (2006–2024)

The table below shows the annual cash flow conversion efficiency of Laboratorios Richmond SACIF from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see RICH stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AR$65.35 Billion ≈ $47.29 Million	AR$5.62 Billion ≈ $4.07 Million	0.086x	+194.63%
2023-12-31	AR$49.98 Billion ≈ $36.17 Million	AR$-4.54 Billion ≈ $-3.29 Million	-0.091x	+78.32%
2022-12-31	AR$10.22 Billion ≈ $7.39 Million	AR$-4.29 Billion ≈ $-3.10 Million	-0.419x	-131.00%
2021-12-31	AR$5.38 Billion ≈ $3.89 Million	AR$7.27 Billion ≈ $5.26 Million	1.353x	+2622.42%
2020-12-31	AR$3.38 Billion ≈ $2.45 Million	AR$-181.33 Million ≈ $-131.21K	-0.054x	-193.08%
2019-12-31	AR$2.10 Billion ≈ $1.52 Million	AR$121.02 Million ≈ $87.57K	0.058x	+135.14%
2018-12-31	AR$1.11 Billion ≈ $803.87K	AR$-182.16 Million ≈ $-131.81K	-0.164x	-1109.58%
2017-12-31	AR$688.05 Million ≈ $497.88K	AR$11.18 Million ≈ $8.09K	0.016x	+183.82%
2016-12-31	AR$189.46 Million ≈ $137.09K	AR$-3.67 Million ≈ $-2.66K	-0.019x	+92.67%
2015-12-31	AR$96.12 Million ≈ $69.55K	AR$-25.42 Million ≈ $-18.40K	-0.264x	-477.45%
2011-12-31	AR$50.10 Million ≈ $36.26K	AR$3.51 Million ≈ $2.54K	0.070x	-62.15%
2010-12-31	AR$44.82 Million ≈ $32.43K	AR$8.30 Million ≈ $6.00K	0.185x	+694.54%
2009-12-31	AR$53.73 Million ≈ $38.88K	AR$1.25 Million ≈ $905.95	0.023x	-95.41%
2007-12-31	AR$13.25 Million ≈ $9.59K	AR$6.73 Million ≈ $4.87K	0.508x	-69.41%
2006-12-31	AR$7.75 Million ≈ $5.61K	AR$12.87 Million ≈ $9.31K	1.661x	--

About Laboratorios Richmond SACIF

BA:RICH Argentina Drug Manufacturers - Specialty & Generic

Market Cap

$79.02 Million

AR$109.20 Billion ARS

Market Cap Rank

#20097 Global

#55 in Argentina

Share Price

AR$1640.00

Change (1 day)

+3.14%

52-Week Range

AR$970.00 - AR$2165.00

All Time High

AR$2165.00